for locomotor activity, exploration and anxiety

Key features
How to order


ActiTrack controls data coming from up to 32 IR frames. It discriminates and analyses frequency and number of IR beam breaks to convert it in a track file that can be analysed later for generating reports. Thus ActiTrack provides much more integrated and precise data in terms of animal activity, position, displacements and rearings than those provided by the SeDaCom software.

The IR actimeter enclosure can be divided into zones of interest (up to 32) using the specific tools provided by Actitrack. Animal trajectories are acquired from real time beam breaks and stored enabling the user to analyze and re-analyse experiments with different zone configurations, associations (user-defined combination of zones) and parameters. Track can be replayed in real-time or by using an "accelerated" (user-defined speed) or "instantaneous" modes. The report cover either the full track or partial sections of time.
All data obtained by Actitrack is expressed in ASCII format and can be easily exported to a wide range of spreadsheets and statistics programs for further analysis. Actitrack can be installed in as many computers as required, and the user will be able to check data, generate reports, print out results and obtain charts for visual presentation.



Computer requirements

2.2 GHz Processor or higher (Celeron processor excluded), 2 Gb of RAM, 150 MB HD, Graphics 1024x768 pixels and 32-bit true colour.

System requirements

Windows™ XP (SP2 or higher), Vista 32, Windows 7 or Windows 8 compatible operating system.

Communication ports

1 free USB port for the License key; 1 RS232 port or additional USB port for the connection to the boxes.


  • Abedi PM et al. (2013) Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat. Neuroscience. Volume 236, 16 April 2013, Pages 289–297 (rat, France, Marocco)
  • Casarejos MJ et al. (2013) Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. Journal of Alzheimer's Disease, Volume 35, Number 3: 525-539. (mouse, Spain)
  • Chetrit J et al. (2013) Inhibiting Subthalamic D5 Receptor Constitutive Activity Alleviates Abnormal Electrical Activity and Reverses Motor Impairment in a Rat Model of Parkinson's Disease. The Journal of Neuroscience, 33(37): 14840-14849 (rat, France).
  • Garcia-Rios RI et al. (2013) Anxiolytic-Like Actions of Fatty Acids Identified in Human Amniotic Fluid. The Scientific World Journal. Volume 2013 (2013), Article ID 823289, 6 pages. (rat, mexico)
  • Llorente-Foch I et al. (2013) AGC1-malate aspartate shuttle activity is critical for dopamine handling in the nigrostriatal pathway. Journal of Neurochemistry. Volume 124, Issue 3, pages 347–362. (mice, Spain, Japan)
  • Lutz PE et al. (2013) A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice. Behavioural Brain Research, Volume 243, 15 April 2013, Pages 44–52. (mice, Canada, France)
  • Mantha K et al. (2013) Neurodevelopmental Timing of Ethanol Exposure May Contribute to Observed Heterogeneity of Behavioral Deficits in a Mouse Model of Fetal Alcohol Spectrum Disorder (FASD). Journal of Behavioral and Brain Science, 2013, 3, 85-99. (mouse, Canada)
  • Rodríguez-Landa JF (2013) Participation of GABAA Chloride Channels in the Anxiolytic-Like Effects of a Fatty Acid Mixture. BioMed Research International, Article ID 121794. (rat, Mexico)
  • Nobrega C et al. (2013) Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice. PLoS ONE 8(1): e52396. doi:10.1371/journal.pone.0052396. (mouse, Portugal).
  • Shin JC et al. (2013) The flavonoid myricetin reduces nocturnal melatonin levels in the blood through the inhibition of serotonin N-acetyltransferase. Biochemical and Biophysical Research Communications. Volume 440, Issue 2, 18 October 2013, Pages 312–316. (rat, South Korea).
  • Delaville C et al. (2013) Activation of subthalamic alpha 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing. Neurobiology of Disease. Volume 47, Issue 3, September 2012, Pages 322–330. (rat, France)
  • Diaz-Alonso J et al. (2012) The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis. The Journal of Neuroscience, 32(47): 16651-16665 (mice, Spain, Germany, UK)
  • Laloux C et al. (2012) Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease. Pharmacological Research, Volume 65, Issue 5, May 2012, Pages 514–522. (mouse, France)
  • Lesmana R et al. (2012) Lactational exposure to hydroxylated polychlorinated biphenyl (OH-PCB 106) causes hyperactivity in male rat pups by aberrant increase in dopamine and its receptor. Environmental Toxicology. (rat, Japan, Indonesia)
  • Sabbar et al. (2012) Lead intoxication induces noradrenaline depletion, motor nonmotor disabilities, and changes in the firing pattern of subthalamic nucleus neurons. Neuroscience Volume 210, 17 May 2012, Pages 375–383. (rat, France)
  • Blazquez C et al. (2011) Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease. Brain 134 (1): 119-136. (mouse, Spain)
  • Garcia C et al (2011) Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease. British Journal of Pharmacology. Volume 163, Issue 7, pages 1495–1506 (rat, Spain, UK)
  • Kleiber et al. (2011) Maternal voluntary drinking in C57BL/6J mice: Advancing a model for fetal alcohol spectrum disorders. Behavioural Brain Research. Volume 223, Issue 2, 1 October 2011, Pages 376–387. (mouse, Canada)
  • Perucho J et al. (2010) Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease.J. Alzheimer’s Disease. 19(4): 1245-57. (Mouse, Spain)
  • Chetrit J et al. (2009) Involvement of Basal Ganglia Network in Motor Disabilities Induced by Typical Antipsychotics. PLoS One. 4(7):e6208. (Open-field with Actitrack, rat, France).
  • Lamberty Y et al. (2009) Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice. Behav. Brain Res. 198(2):329-333. (mouse, Belgium)
  • Tsuchida R et al. (2009) An Antihyperkinetic Action by the Serotonin 1A–Receptor Agonist Osemozotan Co-administered With Psychostimulants or the Non-stimulant Atomoxetine in Mice. J. Pharmacological Sci. 109(3):396-402. (locomotion, mouse, Japan)
  • Goeldner C et al. (2008) Nociceptin Receptor Impairs Recognition Memory via Interaction with NMDA Receptor-Dependent Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling in the Hippocampus. J Neurosci., 28(9):2190 –2198. (object-recognition test, mouse, France)
  • Le Pen G et al. (2008) Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. Parkinsonism Relat Disord. 14 Suppl 2:S107-11. (mouse, France)
  • Rubio M (2008) CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. Neuropharmacology. 54(6):976-988 (rat, Spain, USA)
  • Reiss D et al (2007) Effects of social crowding on emotionality and expression of hippocampal nociceptin/orphanin FQ system transcripts in mice. Behav. Brain Res. 184(2):167-173 (mouse, France)
  • Kucerova J et al. (2006) Gender differences in cannabinoid and ecstasy interacting effects in mice. Homeostasis in health and diseases. 2006(1-2): 95-96. (mouse, Czech Republic)
  • Menendez J et al. (2006) Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein. Human Molecular Genetics. 15(13): 2045-2058. (mouse, Spain)
  • Tanaka et al. (2006) Psychostimulant-Induced Attenuation of Hyperactivity and Prepulse Inhibition Deficits in Adcyap1-Deficient Mice. J. Neurosci. 26(19): 5091-5097. (mouse, Japan)
  • Besson V et al. (2005) Training and aging modulate the loss-of-balance phenotype observed in a new ENU-induced allele of Otopetrin1. Biol. Cell 97(10):787-798. (open-field, mice, France)
  • Cabranes A et al. (2005) Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol. Dis. 20(2):207-217. (rat, Spain)
  • Diguet E, Fernagut PO, Scherfler C, Wenning G, Tison F (2005) Effects of riluzole on combined MPTP +3-nitropropionic acid-induced mild to moderate stiatonigral degeneration in mice. J. Neural. Transm. 112(5): 613-631. (mice, France)
  • Diguet E et al. (2004) Deleterious effects of minocycline in animal models of Parkinson’s disease and Huntington’s disease. Eur. J. Neurosci. 19(12): 3266. (mice, France)
  • Landa L, Pistoveakova J, Suleova A (2003) Behavioural cannabinoid cross-sensitization to the effect of methamphetamine on exploratory/locomotor behaviour in mice. Journal of Prevention, Treatment and Research of addictions (Adiktologie) 2003/III/II, p5. (activity, mice, Czech Republic)


How to order




ACTITRACK Tracking Software for up to 32 frames.



Upgrade from previous version to ACTITRACK V2.7.


How to order

Please contact our local delegates or contact us directly for receiving a quote.


Key features

  • Control up to 32 frames
  • Provides integrated data (spatial position, pattern of displacement, rearings)
  • User-adjustable thresholds for classifying activity into fast, slow and resting movements
  • Allows track re-analysis with an unlimited number of user-defined zones
  • Enables re-playing experiment using different threshold for movement speed definition
  • Can be installed in as many computers as may be required for track analyses


We use own and third-party cookies to improve our services and to show ads related to your preferences by analyzing your browsing habits. If you continue browsing, we will consider that you allow us to use them. You can change the settings or get more information on our Cookies Policy.
More information